“…Previous studies have shown that radiomics in computed tomography (CT) imaging can improve the prediction of prognosis of HNSCC . Radiomics on CT HNSCC imaging has been used to predict HPV status [8,9], overall survival [10][11][12][13][14], progression-free survival [10,[12][13][14], local tumour control [8,12,[15][16][17][18][19][20][21], tumour grade [9,22], lymph node response [23,24], tumour invasiveness [9,25], xerostomia [26][27][28], tumour resectability [29], and classifying molecular subtypes [30,31]. While the survival studies show that radiomics on CT data can significantly stratify patients in multiple survival groups, performance expressed through Harrell's C index ranged widely, from 0.58 to 0.9.…”